Skip to main content
HairCited

Microagulhamento para Alopecia Androgenética

A

Baseado em 52 estudos (5 meta-analyses, 11 RCTs) com 8,451 participantes no total. 44/52 estudos mostram efeitos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusão

Microneedling has strong, well-established evidence for androgenetic alopecia, particularly when combined with topical minoxidil, and is one of the best-supported adjunct therapies for pattern hair loss.

  • 44 out of 52 studies show positive effects, supported by 5 meta-analyses and 11 RCTs
  • Most effective when combined with topical minoxidil, significantly boosting its effectiveness
  • Stimulates growth factors and wound-healing pathways that support hair follicle regeneration
  • Both professional and at-home microneedling approaches have demonstrated benefits

Key Study Findings

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo Efeito: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) vs: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment Efeito: None None

População: Adult males with androgenetic alopecia

Review
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Dose: None vs: None Outcome: None Efeito: None None

População: None

review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Efeito: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Efeito: None None

Key Statistics

62

Estudos

8574

Participantes

Positive

A

Nota

Referenced Papers

Aesthetic plastic surgery 2025 14 citações
Journal of cutaneous … 2025 2 citações
Dermatology (Basel, Switzerland) 2024 14 citações
Journal of cosmetic … 2024 11 citações
Journal of clinical … 2024 10 citações
Clinical, cosmetic and … 2023 58 citações
Skin appendage disorders 2023 4 citações
Faculty reviews 2022 44 citações
Dermatology and therapy 2022 43 citações
Journal of cosmetic … 2022 35 citações
Dermatologic surgery : … 2022 15 citações
Dermatologic surgery : … 2021 58 citações
Dermatologic therapy 2020 48 citações
Journal of plastic, … 2018 137 citações
Journal of the … 2018 114 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

hairloss:
1.5 mm depth, weekly sessions

Limite superior: Not applicable

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
None -- Mixed --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Mixed --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Positive 631
None -- Mixed --

Melhor horário: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Efeitos Colaterais Relatados

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Interações Conhecidas

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Ingestão máxima tolerável: Not applicable

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Microagulhamento help with Alopecia Androgenética?
Based on 62 studies with 8,574 participants, there is strong evidence from multiple clinical trials that Microagulhamento may support Alopecia Androgenética management. Our evidence grade is A (Strong Evidence).
How much Microagulhamento should I take for Alopecia Androgenética?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Microagulhamento?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Microagulhamento and Alopecia Androgenética?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 62 peer-reviewed studies with 8,574 total participants. The overall direction of effect is positive.

Related Evidence

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.